Click here to get full coverage on Is SEPN still worth holding after the dip - Trade Entry Summary & Detailed Earnings Play Strategies - newser.com

Is SEPN still worth holding after the dip - Trade Entry Summary & Detailed Earnings Play Strategies  newser.com

Is SEPN still worth holding after the dip - Trade Entry Summary & Detailed Earnings Play Strategies - newser.com

Click here to get full coverage on HC Wainwright & Co. Maintains Septerna (SEPN) Buy Recommendation - Nasdaq

HC Wainwright & Co. Maintains Septerna (SEPN) Buy Recommendation  Nasdaq

HC Wainwright & Co. Maintains Septerna (SEPN) Buy Recommendation - Nasdaq

Click here to get full coverage on HC Wainwright & Co. Raises Price Target for SEPN to $30.00 | SEP - GuruFocus

HC Wainwright & Co. Raises Price Target for SEPN to $30.00 | SEP  GuruFocus

HC Wainwright & Co. Raises Price Target for SEPN to $30.00 | SEP - GuruFocus

Click here to get full coverage on Septerna, Inc. (SEPN) Reports Q3 Loss, Misses Revenue Estimates - sharewise.com

Septerna, Inc. (SEPN) Reports Q3 Loss, Misses Revenue Estimates  sharewise.com

Septerna, Inc. (SEPN) Reports Q3 Loss, Misses Revenue Estimates - sharewise.com

Click here to get full coverage on Is SEPN stock attractive for long term wealth building - Earnings Trend Report & Capital Efficient Trade Techniques - newser.com

Is SEPN stock attractive for long term wealth building - Earnings Trend Report & Capital Efficient Trade Techniques  newser.com

Is SEPN stock attractive for long term wealth building - Earnings Trend Report & Capital Efficient Trade Techniques - newser.com

Click here to get full coverage on Analysts Offer Insights on Technology Companies: Lightpath Technologies (LPTH) and Septerna, Inc. (SEPN) - The Globe and Mail

Analysts Offer Insights on Technology Companies: Lightpath Technologies (LPTH) and Septerna, Inc. (SEPN)  The Globe and Mail

Analysts Offer Insights on Technology Companies: Lightpath Technologies (LPTH) and Septerna, Inc. (SEPN) - The Globe and Mail

Click here to get full coverage on Strength Seen in Septerna, Inc. (SEPN): Can Its 7.0% Jump Turn into More Strength? - Yahoo Finance

Strength Seen in Septerna, Inc. (SEPN): Can Its 7.0% Jump Turn into More Strength?  Yahoo Finance

Strength Seen in Septerna, Inc. (SEPN): Can Its 7.0% Jump Turn into More Strength? - Yahoo Finance

Click here to get full coverage on Earnings Flash (SEPN) Septerna, Inc. Reports Q3 Revenue $21.5M, vs. FactSet Est of $91.7M - MarketScreener

Earnings Flash (SEPN) Septerna, Inc. Reports Q3 Revenue $21.5M, vs. FactSet Est of $91.7M  MarketScreener

Earnings Flash (SEPN) Septerna, Inc. Reports Q3 Revenue $21.5M, vs. FactSet Est of $91.7M - MarketScreener

Click here to get full coverage on Septerna (NASDAQ: SEPN) to join Nov. 10 & 12 Guggenheim and TD Cowen fireside chats - Stock Titan

Septerna (NASDAQ: SEPN) to join Nov. 10 & 12 Guggenheim and TD Cowen fireside chats  Stock Titan

Septerna (NASDAQ: SEPN) to join Nov. 10 & 12 Guggenheim and TD Cowen fireside chats - Stock Titan

Click here to get full coverage on How SEPN stock trades during market volatility - 2025 Retail Activity & Verified Entry Point Signals - newser.com

How SEPN stock trades during market volatility - 2025 Retail Activity & Verified Entry Point Signals  newser.com

How SEPN stock trades during market volatility - 2025 Retail Activity & Verified Entry Point Signals - newser.com

Click here to get full coverage on Is SEPN still worth holding after the dip - Trade Exit Report & Fast Exit Strategy with Risk Control - newser.com

Is SEPN still worth holding after the dip - Trade Exit Report & Fast Exit Strategy with Risk Control  newser.com

Is SEPN still worth holding after the dip - Trade Exit Report & Fast Exit Strategy with Risk Control - newser.com

Click here to get full coverage on What margin trends mean for SEPN stock - Quarterly Profit Report & AI Powered Market Trend Analysis - newser.com

What margin trends mean for SEPN stock - Quarterly Profit Report & AI Powered Market Trend Analysis  newser.com

What margin trends mean for SEPN stock - Quarterly Profit Report & AI Powered Market Trend Analysis - newser.com

Click here to get full coverage on Is SEPN still worth holding after the dip - Day Trade & Real-Time Stock Price Movement Reports - newser.com

Is SEPN still worth holding after the dip - Day Trade & Real-Time Stock Price Movement Reports  newser.com

Is SEPN still worth holding after the dip - Day Trade & Real-Time Stock Price Movement Reports - newser.com

Click here to get full coverage on Is SEPN stock attractive for long term wealth building - Trade Ideas & AI Enhanced Trading Signals - newser.com

Is SEPN stock attractive for long term wealth building - Trade Ideas & AI Enhanced Trading Signals  newser.com

Is SEPN stock attractive for long term wealth building - Trade Ideas & AI Enhanced Trading Signals - newser.com

Click here to get full coverage on Applying chart zones and confluence areas to SEPN - Insider Selling & Free Expert Verified Stock Movement Alerts - newser.com

Applying chart zones and confluence areas to SEPN - Insider Selling & Free Expert Verified Stock Movement Alerts  newser.com

Applying chart zones and confluence areas to SEPN - Insider Selling & Free Expert Verified Stock Movement Alerts - newser.com

Click here to get full coverage on Is SEPN stock attractive for long term wealth building - July 2025 Momentum & Fast Gain Swing Alerts - newser.com

Is SEPN stock attractive for long term wealth building - July 2025 Momentum & Fast Gain Swing Alerts  newser.com

Is SEPN stock attractive for long term wealth building - July 2025 Momentum & Fast Gain Swing Alerts - newser.com

Click here to get full coverage on What margin trends mean for SEPN stock - Wall Street Watch & Verified Technical Signals - newser.com

What margin trends mean for SEPN stock - Wall Street Watch & Verified Technical Signals  newser.com

What margin trends mean for SEPN stock - Wall Street Watch & Verified Technical Signals - newser.com

Click here to get full coverage on What candlestick patterns are forming on SEPN - Market Performance Recap & Real-Time Sentiment Analysis - newser.com

What candlestick patterns are forming on SEPN - Market Performance Recap & Real-Time Sentiment Analysis  newser.com

What candlestick patterns are forming on SEPN - Market Performance Recap & Real-Time Sentiment Analysis - newser.com

Click here to get full coverage on Applying chart zones and confluence areas to SEPN - Weekly Market Outlook & Stepwise Trade Signal Implementation - newser.com

Applying chart zones and confluence areas to SEPN - Weekly Market Outlook & Stepwise Trade Signal Implementation  newser.com

Applying chart zones and confluence areas to SEPN - Weekly Market Outlook & Stepwise Trade Signal Implementation - newser.com

Click here to get full coverage on Reversal indicators forming on SEPN stock - July 2025 PreEarnings & Risk Controlled Daily Trade Plans - newser.com

Reversal indicators forming on SEPN stock - July 2025 PreEarnings & Risk Controlled Daily Trade Plans  newser.com

Reversal indicators forming on SEPN stock - July 2025 PreEarnings & Risk Controlled Daily Trade Plans - newser.com

Click here to get full coverage on What candlestick patterns are forming on SEPN - 2025 Earnings Impact & Technical Entry and Exit Tips - newser.com

What candlestick patterns are forming on SEPN - 2025 Earnings Impact & Technical Entry and Exit Tips  newser.com

What candlestick patterns are forming on SEPN - 2025 Earnings Impact & Technical Entry and Exit Tips - newser.com

Click here to get full coverage on Septerna, Inc. SEC 10-Q Report - TradingView

Septerna, Inc. SEC 10-Q Report  TradingView

Septerna, Inc. SEC 10-Q Report - TradingView

Click here to get full coverage on Is SEPN stock poised for growth - July 2025 Trends & Free Real-Time Market Sentiment Alerts - newser.com

Is SEPN stock poised for growth - July 2025 Trends & Free Real-Time Market Sentiment Alerts  newser.com

Is SEPN stock poised for growth - July 2025 Trends & Free Real-Time Market Sentiment Alerts - newser.com

Click here to get full coverage on We're Not Worried About Septerna's (NASDAQ:SEPN) Cash Burn - simplywall.st

We're Not Worried About Septerna's (NASDAQ:SEPN) Cash Burn  simplywall.st

We're Not Worried About Septerna's (NASDAQ:SEPN) Cash Burn - simplywall.st

Click here to get full coverage on Institutional scanner results for SEPN - 2025 Short Interest & Long-Term Safe Investment Plans - newser.com

Institutional scanner results for SEPN - 2025 Short Interest & Long-Term Safe Investment Plans  newser.com

Institutional scanner results for SEPN - 2025 Short Interest & Long-Term Safe Investment Plans - newser.com

Click here to get full coverage on Cantor Fitzgerald reiterates Overweight rating on Septerna stock - Investing.com

Cantor Fitzgerald reiterates Overweight rating on Septerna stock  Investing.com

Cantor Fitzgerald reiterates Overweight rating on Septerna stock - Investing.com

Click here to get full coverage on Former Prime Medicine CEO and 20+ Drug Approval Leader Keith Gottesdiener Joins Septerna's Board - Stock Titan

Former Prime Medicine CEO and 20+ Drug Approval Leader Keith Gottesdiener Joins Septerna's Board  Stock Titan

Former Prime Medicine CEO and 20+ Drug Approval Leader Keith Gottesdiener Joins Septerna's Board - Stock Titan

Click here to get full coverage on New Analyst Forecast: $SEPN Given $18.0 Price Target - Nasdaq

New Analyst Forecast: $SEPN Given $18.0 Price Target  Nasdaq

New Analyst Forecast: $SEPN Given $18.0 Price Target - Nasdaq

Click here to get full coverage on We Think Septerna (NASDAQ:SEPN) Can Afford To Drive Business Growth - 富途牛牛

We Think Septerna (NASDAQ:SEPN) Can Afford To Drive Business Growth  富途牛牛

We Think Septerna (NASDAQ:SEPN) Can Afford To Drive Business Growth - 富途牛牛

Click here to get full coverage on Does Septerna, Inc. (SEPN) Have the Potential to Rally 151.27% as Wall Street Analysts Expect? - Nasdaq

Does Septerna, Inc. (SEPN) Have the Potential to Rally 151.27% as Wall Street Analysts Expect?  Nasdaq

Does Septerna, Inc. (SEPN) Have the Potential to Rally 151.27% as Wall Street Analysts Expect? - Nasdaq

Click here to get full coverage on Septerna Up 12%, Insider Buyers Are Up 219% - Yahoo Finance

Septerna Up 12%, Insider Buyers Are Up 219%  Yahoo Finance

Septerna Up 12%, Insider Buyers Are Up 219% - Yahoo Finance

Click here to get full coverage on Will SEPN benefit from macro trends - July 2025 Weekly Recap & Technical Pattern Based Buy Signals - newser.com

Will SEPN benefit from macro trends - July 2025 Weekly Recap & Technical Pattern Based Buy Signals  newser.com

Will SEPN benefit from macro trends - July 2025 Weekly Recap & Technical Pattern Based Buy Signals - newser.com

Click here to get full coverage on H.C. Wainwright Maintains Septerna(SEPN.US) With Buy Rating, Raises Target Price to $30 - 富途牛牛

H.C. Wainwright Maintains Septerna(SEPN.US) With Buy Rating, Raises Target Price to $30  富途牛牛

H.C. Wainwright Maintains Septerna(SEPN.US) With Buy Rating, Raises Target Price to $30 - 富途牛牛

Click here to get full coverage on Worldline to Expand Network Based on Scion Technology - finews.com

Worldline to Expand Network Based on Scion Technology  finews.com

Worldline to Expand Network Based on Scion Technology - finews.com

Click here to get full coverage on GPCR Drug Discovery Pioneer Septerna to Present Latest Updates at Major September Healthcare Conferences - Stock Titan

GPCR Drug Discovery Pioneer Septerna to Present Latest Updates at Major September Healthcare Conferences  Stock Titan

GPCR Drug Discovery Pioneer Septerna to Present Latest Updates at Major September Healthcare Conferences - Stock Titan

Click here to get full coverage on Will Septerna’s (SEPN) Latest Board Appointment Strengthen Its R&D Edge or Reinforce the Status Quo? - simplywall.st

Will Septerna’s (SEPN) Latest Board Appointment Strengthen Its R&D Edge or Reinforce the Status Quo?  simplywall.st

Will Septerna’s (SEPN) Latest Board Appointment Strengthen Its R&D Edge or Reinforce the Status Quo? - simplywall.st

Click here to get full coverage on Septerna Lands Massive $2.2B Novo Nordisk Partnership to Revolutionize Oral Diabetes and Obesity Treatments - Stock Titan

Septerna Lands Massive $2.2B Novo Nordisk Partnership to Revolutionize Oral Diabetes and Obesity Treatments  Stock Titan

Septerna Lands Massive $2.2B Novo Nordisk Partnership to Revolutionize Oral Diabetes and Obesity Treatments - Stock Titan

Click here to get full coverage on Analysts Think These Stocks Could More Than Double in Value - MarketBeat

Analysts Think These Stocks Could More Than Double in Value  MarketBeat

Analysts Think These Stocks Could More Than Double in Value - MarketBeat

Click here to get full coverage on Septerna: Deal With Novo Nordisk Is A Game Changer, While It Still Trades Well Below Net Cash - Seeking Alpha

Septerna: Deal With Novo Nordisk Is A Game Changer, While It Still Trades Well Below Net Cash  Seeking Alpha

Septerna: Deal With Novo Nordisk Is A Game Changer, While It Still Trades Well Below Net Cash - Seeking Alpha

Click here to get full coverage on SEPN Shares Plummet: Still a Hope? - timothysykes.com

SEPN Shares Plummet: Still a Hope?  timothysykes.com

SEPN Shares Plummet: Still a Hope? - timothysykes.com

Click here to get full coverage on How sustainable is SEPN stock dividend payout - Weekly Investment Summary & Real-Time Volume Trigger Notifications - Fundação Cultural do Pará

How sustainable is SEPN stock dividend payout - Weekly Investment Summary & Real-Time Volume Trigger Notifications  Fundação Cultural do Pará

How sustainable is SEPN stock dividend payout - Weekly Investment Summary & Real-Time Volume Trigger Notifications - Fundação Cultural do Pará

Click here to get full coverage on Analysts Offer Insights on Technology Companies: Septerna, Inc. (SEPN) and Cisco Systems (CSCO) - The Globe and Mail

Analysts Offer Insights on Technology Companies: Septerna, Inc. (SEPN) and Cisco Systems (CSCO)  The Globe and Mail

Analysts Offer Insights on Technology Companies: Septerna, Inc. (SEPN) and Cisco Systems (CSCO) - The Globe and Mail

Click here to get full coverage on Septerna Updates Presentation on Drug Discovery Progress - TipRanks

Septerna Updates Presentation on Drug Discovery Progress  TipRanks

Septerna Updates Presentation on Drug Discovery Progress - TipRanks

Click here to get full coverage on Septerna, Inc. Expands Board with New R&D Chair - TipRanks

Septerna, Inc. Expands Board with New R&D Chair  TipRanks

Septerna, Inc. Expands Board with New R&D Chair - TipRanks

Click here to get full coverage on Companies Like Septerna (NASDAQ:SEPN) Are In A Position To Invest In Growth - Sahm

Companies Like Septerna (NASDAQ:SEPN) Are In A Position To Invest In Growth  Sahm

Companies Like Septerna (NASDAQ:SEPN) Are In A Position To Invest In Growth - Sahm

Click here to get full coverage on Septerna Announces Collaboration with Novo Nordisk - TipRanks

Septerna Announces Collaboration with Novo Nordisk  TipRanks

Septerna Announces Collaboration with Novo Nordisk - TipRanks

Click here to get full coverage on Septerna: Great In Theory, Needs Proof - Seeking Alpha

Septerna: Great In Theory, Needs Proof  Seeking Alpha

Septerna: Great In Theory, Needs Proof - Seeking Alpha

Click here to get full coverage on We Think Septerna (NASDAQ:SEPN) Can Easily Afford To Drive Business Growth - 富途牛牛

We Think Septerna (NASDAQ:SEPN) Can Easily Afford To Drive Business Growth  富途牛牛

We Think Septerna (NASDAQ:SEPN) Can Easily Afford To Drive Business Growth - 富途牛牛

Click here to get full coverage on Wells Fargo Maintains Septerna(SEPN.US) With Hold Rating, Maintains Target Price $18 - 富途牛牛

Wells Fargo Maintains Septerna(SEPN.US) With Hold Rating, Maintains Target Price $18  富途牛牛

Wells Fargo Maintains Septerna(SEPN.US) With Hold Rating, Maintains Target Price $18 - 富途牛牛

Click here to get full coverage on Novo Nordisk's latest bet on obesity pills: $2.2 billion for biotech Septerna - Yahoo Finance

Novo Nordisk's latest bet on obesity pills: $2.2 billion for biotech Septerna  Yahoo Finance

Novo Nordisk's latest bet on obesity pills: $2.2 billion for biotech Septerna - Yahoo Finance

Click here to get full coverage on Septerna Stock Surges on Oral Obesity Drug Deal With Novo Nordisk - Nasdaq

Septerna Stock Surges on Oral Obesity Drug Deal With Novo Nordisk  Nasdaq

Septerna Stock Surges on Oral Obesity Drug Deal With Novo Nordisk - Nasdaq

Click here to get full coverage on Septerna Highlights Company Progress and Reports Third Quarter 2025 Financial Results - The Manila Times

Septerna Highlights Company Progress and Reports Third Quarter 2025 Financial Results  The Manila Times

Septerna Highlights Company Progress and Reports Third Quarter 2025 Financial Results - The Manila Times

Click here to get full coverage on Novo Nordisk, Septerna in $2.2 Billion Obesity Pill Partner Deal (SEPN) - Bloomberg.com

Novo Nordisk, Septerna in $2.2 Billion Obesity Pill Partner Deal (SEPN)  Bloomberg.com

Novo Nordisk, Septerna in $2.2 Billion Obesity Pill Partner Deal (SEPN) - Bloomberg.com

Click here to get full coverage on TD Cowen Maintains Septerna(SEPN.US) With Buy Rating - 富途牛牛

TD Cowen Maintains Septerna(SEPN.US) With Buy Rating  富途牛牛

TD Cowen Maintains Septerna(SEPN.US) With Buy Rating - 富途牛牛

Click here to get full coverage on INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Septerna, Inc. - SEPN - PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Septerna, Inc. - SEPN  PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Septerna, Inc. - SEPN - PR Newswire

Click here to get full coverage on Septerna Begins Phase 1 Trial for SEP-631 - TipRanks

Septerna Begins Phase 1 Trial for SEP-631  TipRanks

Septerna Begins Phase 1 Trial for SEP-631 - TipRanks

Click here to get full coverage on H.C. Wainwright Initiates Septerna(SEPN.US) With Buy Rating, Announces Target Price $26 - 富途牛牛

H.C. Wainwright Initiates Septerna(SEPN.US) With Buy Rating, Announces Target Price $26  富途牛牛

H.C. Wainwright Initiates Septerna(SEPN.US) With Buy Rating, Announces Target Price $26 - 富途牛牛

Click here to get full coverage on Novo Nordisk strikes $2.2 billion deal with Septerna to develop new obesity treatments - Reuters

Novo Nordisk strikes $2.2 billion deal with Septerna to develop new obesity treatments  Reuters

Novo Nordisk strikes $2.2 billion deal with Septerna to develop new obesity treatments - Reuters

Click here to get full coverage on Novo Nordisk, Septerna sign $2.2B deal to develop weight-loss pill - Yahoo Finance

Novo Nordisk, Septerna sign $2.2B deal to develop weight-loss pill  Yahoo Finance

Novo Nordisk, Septerna sign $2.2B deal to develop weight-loss pill - Yahoo Finance

Click here to get full coverage on Septerna stock pops on partnership with Novo Nordisk to develop obesity therapies - Proactive financial news

Septerna stock pops on partnership with Novo Nordisk to develop obesity therapies  Proactive financial news

Septerna stock pops on partnership with Novo Nordisk to develop obesity therapies - Proactive financial news

Click here to get full coverage on Septerna Stock Surges on Oral Obesity Drug Deal With Novo Nordisk - Zacks Investment Research

Septerna Stock Surges on Oral Obesity Drug Deal With Novo Nordisk  Zacks Investment Research

Septerna Stock Surges on Oral Obesity Drug Deal With Novo Nordisk - Zacks Investment Research

Click here to get full coverage on Septerna, Inc. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewswire

Septerna, Inc. Investors: Company Investigated by the Portnoy Law Firm  GlobeNewswire

Septerna, Inc. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewswire

Click here to get full coverage on Septerna Reports Q2 2025 Financial Results and Progress - TipRanks

Septerna Reports Q2 2025 Financial Results and Progress  TipRanks

Septerna Reports Q2 2025 Financial Results and Progress - TipRanks

Click here to get full coverage on Septerna shares plummet following clinical trial halt - Investing.com

Septerna shares plummet following clinical trial halt  Investing.com

Septerna shares plummet following clinical trial halt - Investing.com

Click here to get full coverage on Novo Nordisk A/S: Septerna and Novo Nordisk to collaborate - GlobeNewswire

Novo Nordisk A/S: Septerna and Novo Nordisk to collaborate  GlobeNewswire

Novo Nordisk A/S: Septerna and Novo Nordisk to collaborate - GlobeNewswire

Click here to get full coverage on Novo Nordisk taps Septerna in $2.2bn deal for oral obesity therapies - Yahoo Finance

Novo Nordisk taps Septerna in $2.2bn deal for oral obesity therapies  Yahoo Finance

Novo Nordisk taps Septerna in $2.2bn deal for oral obesity therapies - Yahoo Finance

Click here to get full coverage on Septerna Enters Major Collaboration with Novo Nordisk - TipRanks

Septerna Enters Major Collaboration with Novo Nordisk  TipRanks

SEPN

Price Chart

Key Statistics

Technicals

About SEPN

Latest News

Is SEPN still worth holding after the dip - Trade Entry Summary & Detailed Earnings Play Strategies - newser.com

HC Wainwright & Co. Maintains Septerna (SEPN) Buy Recommendation - Nasdaq

HC Wainwright & Co. Raises Price Target for SEPN to $30.00 | SEP - GuruFocus

Advanced Charts

Top Gainers

Top Losers